New research has identified a drug combination that can bypass the cellular defences of neuroblastoma that lead to relapse.

Scientists have discovered a drug combo that may bypass tumor defenses, offering new hope for children with high-risk ...

According to Australia’s Garvan Institute of Medical Research, the drug combination can bypass the cellular defences these ...

The discovery could improve neuroblastoma treatment -- the most common solid tumour in children outside the brain -- which currently claims nine out of 10 young patients who experience recurrence, Xin ...

Researchers in Australia have identified a drug that can help overcome treatment resistance in relapsed neuroblastoma -- the ...

Australian scientists have discovered that an existing lymphoma drug, romidepsin, can break through treatment resistance in ...

A discovery from Australian researchers could lead to better treatment for children with neuroblastoma, a cancer that currently claims 9 out of 10 young patients who experience recurrence.

However, researchers at the Garvan Institute have found a drug called romidepsin can help reduce tumour growth and the chances of the deadly cancer returning, helping more children survive.

Garvan researchers have identified a drug that can overcome treatment resistance in relapsed neuroblastoma.A discovery from Australian researchers ...

A discovery from Australian researchers could lead to better treatment for children with neuroblastoma, a cancer that ...

A discovery from Australian researchers could lead to better treatment for children with neuroblastoma, a cancer that ...